Filing Details

Accession Number:
0001209191-15-043349
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-05-15 16:28:29
Reporting Period:
2015-05-14
Filing Date:
2015-05-15
Accepted Time:
2015-05-15 16:28:29
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1113148 Infinity Pharmaceuticals Inc. INFI Pharmaceutical Preparations (2834) 330655706
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1375124 Q Adelene Perkins C/O Infinity Pharmaceuticals, Inc.
784 Memorial Drive
Cambridge MA 02139
President & Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2015-05-14 10,000 $12.18 374,432 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 6,833 Indirect By 401(k)
Footnotes
  1. The disposition reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 26, 2014.
  2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $12.01 to $12.50, inclusive. The reporting person undertakes to provide to Infinity Pharmaceuticals, Inc., any security holder of Infinity Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 2.